Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
doxorubicin hydrochloride (as pegylated liposomal) |
has intended active ingredient |
True |
doxorubicin hydrochloride (as pegylated liposomal) |
Inferred relationship |
Some |
1 |
doxorubicin hydrochloride (as pegylated liposomal) 20 mg/10 mL injection, vial |
has intended active ingredient |
True |
doxorubicin hydrochloride (as pegylated liposomal) |
Inferred relationship |
Some |
1582563262 |
doxorubicin hydrochloride (as pegylated liposomal) 20 mg/10 mL injection, vial |
has Australian BoSS |
True |
doxorubicin hydrochloride (as pegylated liposomal) |
Inferred relationship |
Some |
1582563262 |
doxorubicin hydrochloride (as pegylated liposomal) 50 mg/25 mL injection, vial |
has intended active ingredient |
True |
doxorubicin hydrochloride (as pegylated liposomal) |
Inferred relationship |
Some |
974140478 |
doxorubicin hydrochloride (as pegylated liposomal) 50 mg/25 mL injection, vial |
has Australian BoSS |
True |
doxorubicin hydrochloride (as pegylated liposomal) |
Inferred relationship |
Some |
974140478 |
Liposomal Doxorubicin (Sun) 20 mg/10 mL injection, 10 mL vial |
has intended active ingredient |
True |
doxorubicin hydrochloride (as pegylated liposomal) |
Inferred relationship |
Some |
1841535678 |
Liposomal Doxorubicin (Sun) 50 mg/25 mL injection, 25 mL vial |
has intended active ingredient |
True |
doxorubicin hydrochloride (as pegylated liposomal) |
Inferred relationship |
Some |
1031272190 |
Caelyx 20 mg/10 mL injection, 10 mL vial |
has Australian BoSS |
True |
doxorubicin hydrochloride (as pegylated liposomal) |
Inferred relationship |
Some |
772299774 |
Liposomal Doxorubicin (Sun) 50 mg/25 mL injection, 25 mL vial |
has Australian BoSS |
True |
doxorubicin hydrochloride (as pegylated liposomal) |
Inferred relationship |
Some |
1031272190 |
Lipodox 50 mg/25 mL injection, 25 mL vial |
has intended active ingredient |
True |
doxorubicin hydrochloride (as pegylated liposomal) |
Inferred relationship |
Some |
1479406526 |
Caelyx 20 mg/10 mL injection, 10 mL vial |
has intended active ingredient |
True |
doxorubicin hydrochloride (as pegylated liposomal) |
Inferred relationship |
Some |
772299774 |
Liposomal Doxorubicin (Sun) 20 mg/10 mL injection, 10 mL vial |
has Australian BoSS |
True |
doxorubicin hydrochloride (as pegylated liposomal) |
Inferred relationship |
Some |
1841535678 |
Lipodox 20 mg/10 mL injection, 10 mL vial |
has Australian BoSS |
True |
doxorubicin hydrochloride (as pegylated liposomal) |
Inferred relationship |
Some |
1813721762 |
Caelyx 50 mg/25 mL injection, 25 mL vial |
has Australian BoSS |
True |
doxorubicin hydrochloride (as pegylated liposomal) |
Inferred relationship |
Some |
27698530 |
Lipodox 50 mg/25 mL injection, 25 mL vial |
has Australian BoSS |
True |
doxorubicin hydrochloride (as pegylated liposomal) |
Inferred relationship |
Some |
1479406526 |
Caelyx 50 mg/25 mL injection, 25 mL vial |
has intended active ingredient |
True |
doxorubicin hydrochloride (as pegylated liposomal) |
Inferred relationship |
Some |
27698530 |
Lipodox 20 mg/10 mL injection, 10 mL vial |
has intended active ingredient |
True |
doxorubicin hydrochloride (as pegylated liposomal) |
Inferred relationship |
Some |
1813721762 |